News

For a number of years we have mentioned the possibility of a new drug called Alemtuzumab being a potential new treatment for people with MS. On 12 June 2012 the makers, Genzyme, announced that the company has made an official application to the Food and Drugs Administration (FDA) in the US and the European Medicines Agency (EMA).

Fingolimod, under the trade name Gilenya, the first oral drug therapy for the treatment of MS, is now available under the direction of a neurologist. Gilenya is licensed as a second line therapy, making it suitable for people that have failed on conventional first line therapies or those individuals with highly active MS.

The MS Ireland blog is your space to talk about the things that matter to you. It's an opportunity to come together with a community of like-minded people and share your stories, advice and tips. 

Politicians from all parties are being encouraged by carers to sign a petition supporting the swift publication of the long awaited National Carers Strategy and for a timeframe for its implementation.

Launch of the findings of a national survey of neurological carers as part of events to mark National Carers Week 2012

The HSE to now fund the oral therapy

An Irish company specialising in laboratory equipment, Chemical Systems Control, has donated high-tech equipment to NUI Galway to help in the battle against multiple sclerosis.

At the National Carers Week launch in the Mansion House, Dublin with Carers Support Group Limerick. (l-r) Eva O'Dwyer, Sr Josephine Dempsey, Marie McLoughlin, Carol Phelan, Nuala Carey (RTE Presenter), Taragh Donohoe (MS Ireland) and Barry Purcell